An Initial Genetic Analysis of Gemcitabine-Induced High-Grade Neutropenia in Pancreatic Cancer Patients in CALGB 80303 (Alliance)
- Citation:
- Pharmacogenet. Genomics vol 29 (6) 123-131
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- 8
- Parents:
- 2955
- Children:
- None
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, U10CA180836, U10CA180838, U10CA180857, U24CA196171
- Corr. Author:
- Authors:
- Federico Innocenti Chen Jiang Alexander B. Sibley Stefanie Denning Amy S. Etheridge Dorothy Watson Donna Niedzwiecki Ace J. Hatch Herbert I. Hurwitz Andrew B. Nixon Yoichi Furukawa Michiaki Kubo Daniel J. Crona Hedy L. Kindler Howard L. McLeod Mark J. Ratain Kouros Owzar
- Networks:
- LAPS-IL057, LAPS-MA036, LAPS-NC007, LAPS-NC010
- Study
- CALGB-80303
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Pancreatic cancer, Gemcitabine, genotyping, variant, genome-wide, neutropenia, association, clinical trial, single nucleotide polymorphism